These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34165970)

  • 1. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
    Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
    ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy.
    Kim J; Shim MK; Moon Y; Kim J; Cho H; Yun WS; Shim N; Seong JK; Lee Y; Lim DK; Kim K
    J Nanobiotechnology; 2024 Mar; 22(1):109. PubMed ID: 38481326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
    Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
    Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
    [No Abstract]   [Full Text] [Related]  

  • 5. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
    Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
    Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Activation Protein-α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy.
    Sun M; Yao S; Fan L; Fang Z; Miao W; Hu Z; Wang Z
    Small; 2022 Mar; 18(9):e2106296. PubMed ID: 34914185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy.
    Choi J; Park B; Park JY; Shin D; Lee S; Yoon HY; Kim K; Kim SH; Kim Y; Yang Y; Shim MK
    Adv Mater; 2024 Sep; 36(38):e2405475. PubMed ID: 38898702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
    Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy.
    Su L; Pan W; Li X; Zhou X; Ma X; Min Y
    Acta Biomater; 2023 Mar; 158():698-707. PubMed ID: 36563773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
    Duan X; Chan C; Guo N; Han W; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Dec; 138(51):16686-16695. PubMed ID: 27976881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy.
    Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y
    Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.
    Yuan Z; Fan G; Wu H; Liu C; Zhan Y; Qiu Y; Shou C; Gao F; Zhang J; Yin P; Xu K
    Mol Ther; 2021 Oct; 29(10):2931-2948. PubMed ID: 34023507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformable prodrug nanoplatform
    Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
    Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
    Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
    Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
    Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
    Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
    Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.